CW April 2006
Volume 15Issue Number 4 April 2006 ISSN 10593802 Women-Only NSCLC Trial: PIONEER IClinical trials among patients with non-small cell lung cancer (NSCLC) that show better results based on age and gender may confirm an emerging understanding of the role of estrogen in lung cancer, and may point to optimal treatment strategies.
Go to Previous Page Go to Next Page Source & Additional Reading Suresh Ramalingam, Assistant Professor of Medicine, University of Pittsburgh Cancer Institute. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW April 2006Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |
